Announcement on Reception of Investor Research
Filed with SSE · · 3 pages · Chinese
Shandong Lukang Pharmaceutical Co., Ltd. on 6ix
Earlier from Shandong Lukang Pharmaceutical
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Obtaining Drug Registration Certificate by the Holding Subsidiary
- Announcement on Expected Increase in Annual Performance for 2024
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
- Announcement on Abnormal Fluctuations in Stock Trading
Later from Shandong Lukang Pharmaceutical
- Announcement on Convening the 2024 Annual Performance Briefing
- Announcement on Acceptance of Application for Issuance of A Shares to Specific Objects by Shanghai Stock Exchange
- Announcement on Resolution of the 7th (Extraordinary) Meeting of the 11th Board of Directors
- Announcement on Receiving Approval Notice of Marketing Application for Celecoxib as Chemical Active Pharmaceutical Ingredient
- Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Shandong Jurisdiction
Follow Shandong Lukang Pharmaceutical into a list and get an email when it puts out news.
Follow Shandong Lukang Pharmaceutical